The Dividend Yield as of December 2025 (TTM) for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) is 0.59%

According to Hangzhou Tigermed Consulting Co., Ltd.’s latest financial reports and current stock price. The company's current Dividend Yield is 0.59%. This represents a change of 246.32% compared to the average of 0.17% of the last 4 quarters.

Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Historical Dividend Yield (quarterly & annually)

How has 3347.HK Dividend Yield performed in the past?

The mean historical Dividend Yield of Hangzhou Tigermed Consulting Co., Ltd. over the last ten years is 0.57%. The current 0.59% Dividend Yield has changed 2.51% with respect to the historical average. Over the past ten years (40 quarters), 3347.HK's Dividend Yield was at its highest in in the December 2023 quarter at 1.03%. The Dividend Yield was at its lowest in in the September 2021 quarter at 0%.

Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Hangzhou Tigermed Consulting Co., Ltd. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Average Dividend Yield

How has 3347.HK Dividend Yield performed in the past?

The current Dividend Yield of Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) Dividend Yield vs. Peers

How is 3347.HK’s Dividend Yield compared to its peers?

Hangzhou Tigermed Consulting Co., Ltd.’s Dividend Yield is less than Pharmaron Beijing Co., Ltd. (0.69%), less than Sinopharm Group Co. Ltd. (3.76%), greater than XtalPi Holdings Ltd (0%), greater than RemeGen Co., Ltd. (0%), less than Joinn Laboratories(China)Co.,Ltd. (0.08%), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (3.10%), less than Shanghai Pharmaceuticals Holding Co., Ltd (2.06%), greater than WuXi XDC Cayman Inc (0%), greater than Shanghai Henlius Biotech, Inc. (0%), greater than Shanghai Junshi Biosciences Co., Ltd. (0%),

Build a custom stock screener for Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hangzhou Tigermed Consulting Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hangzhou Tigermed Consulting Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.